Compare RANI & GHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
Current Price
| Metric | RANI | GHG |
|---|---|---|
| Founded | 2012 | 2004 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.8M | 126.4M |
| IPO Year | 2021 | 2017 |
| Metric | RANI | GHG |
|---|---|---|
| Price | $0.96 | $1.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | ★ 676.4K | 21.3K |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 4.15% |
| EPS Growth | ★ 57.14 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,633,000.00 | N/A |
| Revenue This Year | $274.77 | $19.02 |
| Revenue Next Year | $79.44 | $8.26 |
| P/E Ratio | ★ N/A | $5.76 |
| Revenue Growth | ★ 58.85 | N/A |
| 52 Week Low | $0.39 | $1.14 |
| 52 Week High | $3.87 | $2.78 |
| Indicator | RANI | GHG |
|---|---|---|
| Relative Strength Index (RSI) | 52.50 | 45.14 |
| Support Level | $0.46 | $1.16 |
| Resistance Level | $1.05 | $1.33 |
| Average True Range (ATR) | 0.07 | 0.04 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 61.01 | 20.00 |
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.